BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jiang L, Huang Y, Zhang Q, He H, Xu Y, Mei X. Preparation and Solid-State Characterization of Dapsone Drug–Drug Co-Crystals. Crystal Growth & Design 2014;14:4562-73. [DOI: 10.1021/cg500668a] [Cited by in Crossref: 55] [Cited by in F6Publishing: 35] [Article Influence: 6.9] [Reference Citation Analysis]
Number Citing Articles
1 Ganduri R, Cherukuvada S, Guru Row TN. Multicomponent Adducts of Pyridoxine: An Evaluation of the Formation of Eutectics and Molecular Salts. Crystal Growth & Design 2015;15:3474-80. [DOI: 10.1021/acs.cgd.5b00546] [Cited by in Crossref: 21] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
2 Thakuria R, Sarma B. Drug‑Drug and Drug‑Nutraceutical Cocrystal/Salt as Alternative Medicine for Combination Therapy: A Crystal Engineering Approach. Crystals 2018;8:101. [DOI: 10.3390/cryst8020101] [Cited by in Crossref: 59] [Cited by in F6Publishing: 19] [Article Influence: 14.8] [Reference Citation Analysis]
3 Yu JW, Jung J, Choi Y, Choi JH, Yu J, Lee JK, You N, Goh M. Enhancement of the crosslink density, glass transition temperature, and strength of epoxy resin by using functionalized graphene oxide co-curing agents. Polym Chem 2016;7:36-43. [DOI: 10.1039/c5py01483b] [Cited by in Crossref: 61] [Cited by in F6Publishing: 1] [Article Influence: 10.2] [Reference Citation Analysis]
4 Essousi H, Barhoumi H, Jaffrezic‐renault N. Molecularly Imprinted Electrochemical Sensor Based on Modified Reduced Graphene Oxide‐gold Nanoparticles‐polyaniline Nanocomposites Matrix for Dapsone Determination. Electroanalysis 2019;31:1050-60. [DOI: 10.1002/elan.201800818] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
5 Bolla G, Mittapalli S, Nangia A. Pentamorphs of Acedapsone. Crystal Growth & Design 2014;14:5260-74. [DOI: 10.1021/cg5010424] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
6 Arenas-garcía JI, Herrera-ruiz D, Morales-rojas H, Höpfl H. Interrelation of the dissolution behavior and solid-state features of acetazolamide cocrystals. European Journal of Pharmaceutical Sciences 2017;96:299-308. [DOI: 10.1016/j.ejps.2016.09.025] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]
7 Rossi F, Cerreia Vioglio P, Bordignon S, Giorgio V, Nervi C, Priola E, Gobetto R, Yazawa K, Chierotti MR. Unraveling the Hydrogen Bond Network in a Theophylline–Pyridoxine Salt Cocrystal by a Combined X-ray Diffraction, Solid-State NMR, and Computational Approach. Crystal Growth & Design 2018;18:2225-33. [DOI: 10.1021/acs.cgd.7b01662] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 3.3] [Reference Citation Analysis]
8 Deng Y, Zhang Y, Huang Y, Zhang M, Lou B. Preparation, Crystal Structures, and Oral Bioavailability of Two Cocrystals of Emodin with Berberine Chloride. Crystal Growth & Design 2018;18:7481-8. [DOI: 10.1021/acs.cgd.8b01257] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
9 Wang J, Wang X, Yang Y, Chen X, Mei X. Solid-state characterization of 17β-estradiol co-crystals presenting improved dissolution and bioavailability. CrystEngComm 2016;18:3498-505. [DOI: 10.1039/c6ce00433d] [Cited by in Crossref: 11] [Article Influence: 1.8] [Reference Citation Analysis]
10 He H, Jiang L, Zhang Q, Huang Y, Wang J, Mei X. Polymorphism observed in dapsone–flavone cocrystals that present pronounced differences in solubility and stability. CrystEngComm 2015;17:6566-74. [DOI: 10.1039/c5ce01208b] [Cited by in Crossref: 22] [Article Influence: 3.1] [Reference Citation Analysis]
11 Xu K, Xiong X, Guo L, Wang L, Li S, Tang P, Yan J, Wu D, Li H. An Investigation into the Polymorphism and Crystallization of Levetiracetam and the Stability of its Solid Form. J Pharm Sci 2015;104:4123-31. [PMID: 26331706 DOI: 10.1002/jps.24628] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
12 Shinozaki T, Ono M, Higashi K, Moribe K. A Novel Drug-Drug Cocrystal of Levofloxacin and Metacetamol: Reduced Hygroscopicity and Improved Photostability of Levofloxacin. J Pharm Sci 2019;108:2383-90. [PMID: 30807761 DOI: 10.1016/j.xphs.2019.02.014] [Cited by in Crossref: 22] [Cited by in F6Publishing: 12] [Article Influence: 7.3] [Reference Citation Analysis]
13 Salem A, Nagy S, Pál S, Széchenyi A. Reliability of the Hansen solubility parameters as co-crystal formation prediction tool. International Journal of Pharmaceutics 2019;558:319-27. [DOI: 10.1016/j.ijpharm.2019.01.007] [Cited by in Crossref: 21] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
14 da Silva CCP, de Melo CC, Souza MS, Diniz LF, Carneiro RL, Ellena J. 5-Fluorocytosine/5-Fluorouracil Drug-Drug Cocrystal: a New Development Route Based on Mechanochemical Synthesis. J Pharm Innov 2019;14:50-6. [DOI: 10.1007/s12247-018-9333-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
15 Wang F, Zhang Q, Zhang Z, Gong X, Wang J, Mei X. Solid-state characterization and solubility enhancement of apremilast drug–drug cocrystals. CrystEngComm 2018;20:5945-8. [DOI: 10.1039/c8ce00689j] [Cited by in Crossref: 24] [Article Influence: 6.0] [Reference Citation Analysis]
16 Todaro V, Worku ZA, Cabral LM, Healy AM. In Situ Cocrystallization of Dapsone and Caffeine during Fluidized Bed Granulation Processing. AAPS PharmSciTech 2019;20. [DOI: 10.1208/s12249-018-1228-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
17 Wang J, Yu Q, Dai W, Mei X. Drug–drug co-crystallization presents a new opportunity for the development of stable vitamins. Chem Commun 2016;52:3572-5. [DOI: 10.1039/c5cc10297a] [Cited by in Crossref: 38] [Cited by in F6Publishing: 2] [Article Influence: 6.3] [Reference Citation Analysis]
18 Li W, Ma Y, Yang Y, Xu S, Shi P, Wu S. Solubility measurement, correlation and mixing thermodynamics properties of dapsone in twelve mono solvents. Journal of Molecular Liquids 2019;280:175-81. [DOI: 10.1016/j.molliq.2019.02.023] [Cited by in Crossref: 23] [Cited by in F6Publishing: 2] [Article Influence: 7.7] [Reference Citation Analysis]
19 Haneef J, Chadha R. Drug-Drug Multicomponent Solid Forms: Cocrystal, Coamorphous and Eutectic of Three Poorly Soluble Antihypertensive Drugs Using Mechanochemical Approach. AAPS PharmSciTech 2017;18:2279-90. [PMID: 28101724 DOI: 10.1208/s12249-016-0701-1] [Cited by in Crossref: 41] [Cited by in F6Publishing: 27] [Article Influence: 8.2] [Reference Citation Analysis]
20 Bolla G, Nangia A. Pharmaceutical cocrystals: walking the talk. Chem Commun (Camb) 2016;52:8342-60. [PMID: 27278109 DOI: 10.1039/c6cc02943d] [Cited by in Crossref: 271] [Cited by in F6Publishing: 33] [Article Influence: 67.8] [Reference Citation Analysis]
21 do Amaral LH, do Carmo FA, Amaro MI, de Sousa VP, da Silva LCRP, de Almeida GS, Rodrigues CR, Healy AM, Cabral LM. Development and Characterization of Dapsone Cocrystal Prepared by Scalable Production Methods. AAPS PharmSciTech 2018;19:2687-99. [DOI: 10.1208/s12249-018-1101-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
22 Nechipadappu SK, R. Trivedi D. Pharmaceutical salts of ethionamide with GRAS counter ion donors to enhance the solubility. European Journal of Pharmaceutical Sciences 2017;96:578-89. [DOI: 10.1016/j.ejps.2016.10.035] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
23 Chaves LL, Vieira AC, Ferreira D, Sarmento B, Reis S. Rational and precise development of amorphous polymeric systems with dapsone by response surface methodology. International Journal of Biological Macromolecules 2015;81:662-71. [DOI: 10.1016/j.ijbiomac.2015.08.009] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
24 Zhu B, Wang J, Zhang Q, Mei X. Improving Dissolution and Photostability of Vitamin K3 via Cocrystallization with Naphthoic Acids and Sulfamerazine. Crystal Growth & Design 2016;16:483-92. [DOI: 10.1021/acs.cgd.5b01491] [Cited by in Crossref: 28] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
25 Thipparaboina R, Kumar D, Chavan RB, Shastri NR. Multidrug co-crystals: towards the development of effective therapeutic hybrids. Drug Discovery Today 2016;21:481-90. [DOI: 10.1016/j.drudis.2016.02.001] [Cited by in Crossref: 122] [Cited by in F6Publishing: 87] [Article Influence: 20.3] [Reference Citation Analysis]
26 Eesam S, Bhandaru JS, Naliganti C, Bobbala RK, Akkinepally RR. Solubility enhancement of carvedilol using drug–drug cocrystallization with hydrochlorothiazide. Futur J Pharm Sci 2020;6. [DOI: 10.1186/s43094-020-00083-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Chaves LL, Silveri A, Vieira ACC, Ferreira D, Cristiano MC, Paolino D, Di Marzio L, Lima SC, Reis S, Sarmento B, Celia C. pH-responsive chitosan based hydrogels affect the release of dapsone: Design, set-up, and physicochemical characterization. Int J Biol Macromol 2019;133:1268-79. [PMID: 31034906 DOI: 10.1016/j.ijbiomac.2019.04.178] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
28 Ngilirabanga JB, Samsodien H. Pharmaceutical co‐crystal: An alternative strategy for enhanced physicochemical properties and drug synergy. Nano Select 2021;2:512-26. [DOI: 10.1002/nano.202000201] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
29 Li W, Shi P, Jia L, Zhao Y, Sun B, Zhang M, Gong J, Tang W. Eutectics and Salt of Dapsone With Hydroxybenzoic Acids: Binary Phase Diagrams, Characterization and Evaluation. J Pharm Sci 2020;109:2224-36. [PMID: 32294458 DOI: 10.1016/j.xphs.2020.04.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
30 Li P, Ramaiah T, Zhang M, Zhang Y, Huang Y, Lou B. Two Cocrystals of Berberine Chloride with Myricetin and Dihydromyricetin: Crystal Structures, Characterization, and Antitumor Activities. Crystal Growth & Design 2020;20:157-66. [DOI: 10.1021/acs.cgd.9b00939] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 3.3] [Reference Citation Analysis]
31 Nechipadappu SK, Tekuri V, Trivedi DR. Pharmaceutical Co-Crystal of Flufenamic Acid: Synthesis and Characterization of Two Novel Drug-Drug Co-Crystal. J Pharm Sci 2017;106:1384-90. [PMID: 28185907 DOI: 10.1016/j.xphs.2017.01.033] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 4.2] [Reference Citation Analysis]
32 Gaytán-Barrientos NS, Morales-Morales D, Herrera-Ruiz D, Reyes-Martínez R, Rivera-Islas J. Sulfonate salts of the therapeutic agent dapsone: 4-[(4-aminophenyl)sulfonyl]anilinium benzenesulfonate monohydrate and 4-[(4-aminophenyl)sulfonyl]anilinium methanesulfonate monohydrate. Acta Crystallogr C Struct Chem 2016;72:280-4. [PMID: 27045177 DOI: 10.1107/S2053229616003284] [Cited by in Crossref: 6] [Article Influence: 1.0] [Reference Citation Analysis]
33 Xuan B, Wong SN, Zhang Y, Weng J, Tong HHY, Wang C, Sun CC, Chow SF. Extended Release of Highly Water Soluble Isoniazid Attained through Cocrystallization with Curcumin. Crystal Growth & Design 2020;20:1951-60. [DOI: 10.1021/acs.cgd.9b01619] [Cited by in Crossref: 13] [Article Influence: 6.5] [Reference Citation Analysis]
34 Chappa P, Maruthapillai A, Voguri R, Dey A, Ghosal S, Basha MA. Drug–Polymer Co-Crystals of Dapsone and Polyethylene Glycol: An Emerging Subset in Pharmaceutical Co-Crystals. Crystal Growth & Design 2018;18:7590-8. [DOI: 10.1021/acs.cgd.8b01397] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
35 Kumari N, Ghosh A. Cocrystallization: Cutting Edge Tool for Physicochemical Modulation of Active Pharmaceutical Ingredients. Curr Pharm Des 2020;26:4858-82. [PMID: 32691702 DOI: 10.2174/1381612826666200720114638] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
36 Raimondo M, Naddeo C, Vertuccio L, Bonnaud L, Dubois P, Binder WH, Sorrentino A, Guadagno L. Multifunctionality of structural nanohybrids: the crucial role of carbon nanotube covalent and non-covalent functionalization in enabling high thermal, mechanical and self-healing performance. Nanotechnology 2020;31:225708. [PMID: 32059201 DOI: 10.1088/1361-6528/ab7678] [Cited by in Crossref: 16] [Cited by in F6Publishing: 4] [Article Influence: 8.0] [Reference Citation Analysis]
37 Sarmah KK, Nath N, Rao DR, Thakuria R. Mechanochemical synthesis of drug–drug and drug–nutraceutical multicomponent solids of olanzapine. CrystEngComm 2020;22:1120-30. [DOI: 10.1039/c9ce01504c] [Cited by in Crossref: 11] [Article Influence: 5.5] [Reference Citation Analysis]
38 Thorat SH, Sahu SK, Patwadkar MV, Badiger MV, Gonnade RG. Drug–Drug Molecular Salt Hydrate of an Anticancer Drug Gefitinib and a Loop Diuretic Drug Furosemide: An Alternative for Multidrug Treatment. Journal of Pharmaceutical Sciences 2015;104:4207-16. [DOI: 10.1002/jps.24651] [Cited by in Crossref: 25] [Cited by in F6Publishing: 17] [Article Influence: 3.6] [Reference Citation Analysis]
39 Barros PD, Dias IFT, Zanin GD, Bunhak ÉJ. Development and evaluation of dapsone tablets coated for specific colon release. Drug Dev Ind Pharm 2020;46:246-52. [PMID: 31951762 DOI: 10.1080/03639045.2020.1716375] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]